Viscadia’s Webinar on Key Patient Flow Constructs in Breast Cancer Forecast Modeling

Press Release (ePRNews.com) - India - Feb 03, 2023 - Diagnosis of Breast Cancer is a life-altering event for anyone. Although there are many resources available to guide patients through the process, it is often overwhelming for them.

Given Breast Cancer’s toll on the patient and the entire family, patient-centricity is a must to achieve the best possible experience and outcome. With the right support and awareness, patients can take greater control of their treatment process.

“Awareness reduces the stigma associated with Breast cancer and educates people on ways to mitigate the risk of developing breast cancer and the benefits of an early diagnosis.”, said Shruti Gupta, Director at Viscadia, the leading firm for life science consulting in Boston.

She further added,” Being aware of the treatment paradigms is a must for patients to make informed choices. Meanwhile, it is imperative for pharmaceutical firms operating in this space to identify the risks associated with commercial assessments. Often pharmaceutical firms find themselves a bit lacking in this aspect and their business decisions might suffer. There is an evident need to demystify it and we are taking the initiative to address the same. We also organized a month-long campaign in October 2022 that was focused on improving patient experiences, treatment paradigms, along with technological innovations in the fight against breast cancer.”

As a part of its initiative, Viscadia is organizing a webinar on the 2nd of February 2023 on key patient flow constructs in Breast Cancer Forecast modeling. This webinar would be focused on analysts, forecast modelers, and key decision-makers in pharma firms. to gain a better understanding of the breast cancer treatment journey, key patient model design constructs, and identification of risk within breast cancer commercial assessments.

Armed with over a decade of experience, Viscadia’s expertise in healthcare forecasting and in the Bio-Pharma industry makes this webinar an incredibly reliable and useful source.